Edition:
United Kingdom

Mersana Therapeutics Inc (MRSN.OQ)

MRSN.OQ on NASDAQ Stock Exchange Global Select Market

3.80USD
17 Jan 2019
Change (% chg)

-- (--)
Prev Close
$3.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
37,017
52-wk High
$23.67
52-wk Low
$3.39

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 2.15 -0.737
Jun '18 4.19 -0.538
Mar '18 3.06 -0.544
FY 2017 Dec '17 3.26 -0.613
Sep '17 6.27 -0.340
Jun '17 3.73 -0.394
Mar '17 4.29 -0.356
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 3 4.69 5.50 3.56 --
Quarter Ending Jun-19 3 4.72 5.50 3.65 --
Year Ending Dec-19 5 20.58 27.00 15.00 25.01
Earnings (per share)
Quarter Ending Mar-19 4 -0.62 -0.49 -0.70 --
Quarter Ending Jun-19 4 -0.64 -0.53 -0.71 --
Year Ending Dec-19 6 -2.39 -1.91 -2.79 -1.91
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta -- 1.08 0.90
Price to Sales (TTM) -- 49.51 6.28
Price to Book (MRQ) -- 10.16 5.27
Price to Tangible Book (MRQ) 18.86 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 78.13 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.04 9.72
Sales (TTM) vs TTM 1 Yr. Ago -- 47.85 5.87
Sales - 5 Yr. Growth Rate -- 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate -- 9.25 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) 2.53 3.43 3.08
LT Debt to Equity (MRQ) 0.00 18.73 11.38
Total Debt to Equity (MRQ) 0.00 31.43 16.13
Interest Coverage (TTM) -- -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.00 12.88
Operating Margin (TTM) -- -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.43 8.32
Pre-Tax Margin (TTM) -- -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.58 8.62
Net Profit Margin (TTM) -- -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -- -136.98 4.89
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,650,742 844,239,900
Net Income/Employee (TTM) -- 652,581 100,064,185
Receivable Turnover (TTM) -- 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) -- 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.45 11.08
Return on Assets - 5 Yr. Avg. -- 5.52 12.21
Return on Investment (TTM) -- 8.99 14.48
Return on Investment - 5 Yr. Avg. -- 6.85 15.88
Return on Equity (TTM) -- 10.13 15.99
Return on Equity - 5 Yr. Avg. -- 8.39 17.00
  1 Year 3 Year 5 Year
Sales % 142.99 -- --
EPS (TTM) % 16.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Mersana Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.92 3.23 99 99
13 Week 42.40 35.47 99 95
26 Week -- -- -- 98
52 Week -- -- -- 72
YTD -- -- -- 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.41%
# of Holders: 79
Total Shares Held: 18,178,059
3 Mo. Net Change: -1,765,054
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 8
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.